Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of oxaliplatin in treating patients who have
relapsed or refractory non-Hodgkin's lymphoma. Drugs used in chemotherapy use different ways
to stop tumor cells from dividing so they stop growing or die